Stockhead’s Prepped and Primed video series is a summary of development plans from company leaders, who share what investors can expect to see in the year ahead.

In this instalment Fiona Milner, general manager at PharmAust (ASX:PAA) shares her outlook for 2023.

PharmAust Limited is a clinical-stage company developing therapeutics for the treatment of different types of cancers in both humans and animals, viral and neurological diseases. The company specialise in repurposing marketed drugs, lowering the risks and costs of development.

To hear about the company’s upcoming 2023, click above.